Patents Represented by Attorney, Agent or Law Firm Vincent M. Powers
-
Patent number: 5527715Abstract: A method of assaying a human urine sample, by measuring a concentration of pyridinium crosslinks from which the concentration of total hydrolysed pyridinoline in the sample can be determined, is disclosed. In the method, a urine sample is reacted with an anti-Pyd antibody reagent which preferably has a ratio of reactivity toward native free pyridinoline and urinary pyridinoline peptides larger than 1,000 daltons in molecular weight, of greater than 10:1. By measuring the extent of immunocomplex formed by the reaction, the concentration of total hydrolysed pyridinoline in the sample can be calculated. Also disclosed are an antibody reagent and kit which can be used in the method.Type: GrantFiled: March 10, 1994Date of Patent: June 18, 1996Assignee: Metra Biosystems, Inc.Inventors: Viola T. Kung, Mary J. Cerelli, Yuri Daniloff, Robert F. Zuk
-
Patent number: 5521065Abstract: A method of testing for the presence or absence of a target sequence in a mixture of single-stranded nucleic acid fragments is disclosed. The method involves reacting a mixture of single-stranded nucleic acid fragments with a first probe which is complementary to a first region of the target sequence, and with a second probe which is complementary to a second region of the target sequence, where the first and second target regions are contiguous with one another, under hybridization conditions in which the two probes become stably hybridized to their associated target regions. Following hybridization, any of the first and second probes hybridized to contiguous first and second target regions are ligated, and the sample is tested for the presence of expected probe ligation product. The presence of ligated product indicates that the target sequence is present in the sample.Type: GrantFiled: June 8, 1994Date of Patent: May 28, 1996Assignee: Applied Biosystems, Inc.Inventors: Norman M. Whiteley, Michael W. Hunkapiller, Alexander N. Glazer
-
Patent number: 5514543Abstract: Method and composition for detecting one or more selected polynucleotide regions in a target polynucleotide. In one embodiment of the invention, a plurality of different-sequence probe pairs are added to a target polynucleotide, where each probe pair includes two polynucleotide probe elements which are complementary in sequence to adjacent portions of a selected one of the target sequences in the target polynucleotide. In each probe pair, one of the probe elements contains a non-polynucleotide polymer chain which imparts a distinctive mobility to the associated probe pair, when the elements in the pair are ligated. The other element in the pair contains a detectable reporter label. After the probe pairs have been allowed to hybridize with the target polynucleotide, the hybridized polynucleotides are treated under conditions effective to ligate the end subunits of target-bound probe elements when their end subunits are base-paired with adjacent target bases.Type: GrantFiled: August 4, 1993Date of Patent: May 7, 1996Assignee: Applied Biosystems, Inc.Inventors: Paul D. Grossman, Steven Fung, Steven M. Menchen, Sam L. Woo, Emily S. Win-Deen
-
Patent number: 5502197Abstract: A pyridinoline composition in which pyridinoline is derivatized specifically at its aliphatic hydroxyl group by a selected chemical group is disclosed. In various embodiments, the composition may be used as a standard for HPLC or immunoassay of pyridinoline, a pyridinoline immunogen for producing anti-pyridinoline antibodies, and a solid-phase reagent for use in an immunoassay kit. Also disclosed are methods for making and using the composition.Type: GrantFiled: April 28, 1994Date of Patent: March 26, 1996Assignee: Metra Biosystems, Inc.Inventors: Yuri Daniloff, Simon P. Robins, Brian J. Evans, David A. Pratt, Robert Lungard
-
Patent number: 5470705Abstract: Method and composition for detecting one or more selected polynucleotide regions in a target polynucleotide. In the method, a mixture of sequence-specific probes are reacted with the target polynucleotide under hybridization conditions, and the hybridized probes are treated to selectively modify those probes which are bound to the target polynucleotide in a base-specific manner. The resulting labeled probes include a polymer chain which imparts to each different-sequence probe, a distinctive ratio of charge/translational frictional drag, and a detectable label. The labeled probes are fractionated by electrophoresis in a non-sieving matrix, and the presence of one or more selected sequences in the target polynucleotide are detected according to the observed electrophoretic migration rates of the labeled probes in a non-sieving medium.Type: GrantFiled: April 7, 1992Date of Patent: November 28, 1995Assignee: Applied Biosystems, Inc.Inventors: Paul D. Grossman, Steven Fung, Steven M. Menchen, Sam L. Woo, Emily S. Winn-Deen
-
Patent number: 5468772Abstract: An immunosuppressive compound having the structural formula: ##STR1## is disclosed, along with immunosuppression treatment methods which employ the compound.Type: GrantFiled: March 10, 1993Date of Patent: November 21, 1995Assignee: Pharmagenesis, Inc.Inventors: Ren S. Xu, Tien W. Wiedmann
-
Patent number: 5468365Abstract: A viscous electrophoresis separation medium is disclosed. The medium is formed by a matrix formed by a copolymer composed of hydrophilic polymer segments having selected, substantially uniform segment lengths, and a plurality of hydrophobic polymer segments carried on, and spaced from one another by the hydrophilic polymer segments. Also disclosed is an electrophoresis method which employs the separation medium, and novel copolymers used in forming the medium.Type: GrantFiled: September 22, 1993Date of Patent: November 21, 1995Assignee: Applied Biosystems, Inc.Inventors: Steven M. Menchen, Mitchell A. Winnik, Ben F. Johnson
-
Patent number: 5462748Abstract: A cartridge containing a dry polymer composition carrying trapped biopolymer subunits for use in synthesis of biopolymer chains provides a discrete unit for stepwise supply of subunits, such as protected amino acids, in an automated apparatus for biopolymer synthesis. The composition is swellable in organic solvent to release and supply the subunits to a growing biopolymer chain immobilized on a polymer support. An automated synthesizer uses the cartridges for sequential subunit supply and monitors conductivity of deprotection reagents to control cycling and timing of steps.Type: GrantFiled: January 14, 1994Date of Patent: October 31, 1995Assignee: Applied Biosystems, Inc.Inventors: David H. Lloyd, Robert J. DeFranco, Charles S. Ladd
-
Patent number: 5441983Abstract: A method for inhibiting cell infection by an enveloped virus, by administering to an infection site, a therapeutically effective amount of a calix(n)arene compound derivatized, at its ring positions meta to the bridge attachements to the ring, with polar substitutent having a terminal carboxylate, phosphate, or sulfonate groups, including esters and amides which are cleavable in vivo. The compound may be administered orally, or topically, e.g., for treatment of herpes virus.Type: GrantFiled: August 6, 1992Date of Patent: August 15, 1995Assignee: Genelabs IncorporatedInventors: Kou M. Hwang, You M. Qi, Su-Ying Liu, William Choy, Jen Chen
-
Patent number: 5421121Abstract: Method for extending bloom life of a cut flower by bathing the flower in a solution which contains isoniazid. Also disclosed are compositions for use in the method.Type: GrantFiled: September 8, 1994Date of Patent: June 6, 1995Assignee: Epitope, Inc.Inventors: Richard K. Bestwick, Vijaya K. Mokkapati
-
Patent number: 5414791Abstract: Novel acceptor-donor-acceptor compounds for use in forming a thermally-stable electro-optic waveguide are disclosed. Also disclosed is a thermally stable waveguide material containing thermally stable acceptor-donor-acceptor or donor-acceptor-donor guest dipole compounds in dissolved form in a polyimide matrix. The waveguide has selected regions in which the net dipoles of the guest molecules are oriented, for electro-optic switching when an electric field is placed across these regions.Type: GrantFiled: October 5, 1993Date of Patent: May 9, 1995Assignee: Lockheed Missiles & Space Company, Inc.Inventors: Susan P. Ermer, Doris S. Leung, Steven M. Lovejoy
-
Patent number: 5409739Abstract: A process for producing an essentially monolayer coating of crosslinked polymer on a substrate, in which a block copolymer is introduced into a semi-solvent which solvates only one block of the copolymer, the resultant block copolymer semi-solution is contacted with a substrate, and the copolymer is then crosslinked.Type: GrantFiled: September 17, 1993Date of Patent: April 25, 1995Assignee: University Technologies International Inc.Inventor: Guojun Liu
-
Patent number: 5409959Abstract: A method of inhibiting thrombus formation in a mammalian subject. The method involves administering to the subject a therapeutically effective dose of a calix(n)arene compound derivatized, at its ring positions meta to the bridge attachments to the ring, with polar substituents having terminal sulfonate groups, including esters and amides which are cleavable in vivo.Type: GrantFiled: August 6, 1992Date of Patent: April 25, 1995Assignee: Genelabs IncorporatedInventors: Kou M. Hwang, You M. Qi, Su-Ying Liu, Thomas C. Lee, William Choy, Jen Chen
-
Patent number: 5384397Abstract: The invention includes a water-soluble oxygen carrier. The oxygen carrier includes a meso-.alpha.,.alpha.,.alpha.,.alpha.-tetrakis(o-propanoylamino)phenylporph yrin, in which the 3-carbons of the propanoyl groups are each covalently bound to an amine nitrogen, and iron or cobalt is bound to the pyrrole nitrogens of the porphyrin. The oxygen carrier also includes a ligand L for protecting the open face of the porphyrin from .mu.-oxo dimer formation.Type: GrantFiled: November 9, 1993Date of Patent: January 24, 1995Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Xumu Zhang, Erich Uffelman, James P. Collman
-
Patent number: 5374527Abstract: A DNA sequencing method for use in sequencing a DNA target sequence up to 300 bases, preferably up to 500 bases or greater in length, by electrophoretically separating a mixture of single-stranded DNA sequencing fragments in a capillary tube. The method employs an aqueous denaturing solution comprising between about 4 and about 7 weight percent linear polyacrylamide molecules having an average molecular weight of between about 20 and about 100 kDa. The low-viscosity of the solution allows rapid loading and reloading of such solution into the capillary tube.Type: GrantFiled: January 21, 1993Date of Patent: December 20, 1994Assignee: Applied Biosystems, Inc.Inventor: Paul D. Grossman
-
Patent number: 5366954Abstract: The present invention includes a method of extending bloom life of a cut flower. In the method, a storage solution containing 5-deoxy-5-ethylthio-D-ribose (ETR) is provided, and the stem of the cut flower is bathed in the solution. ETR is safe for human use, and is effective at relatively low concentrations. A method for synthesizing 5-deoxy-5-alkylthioribose compounds is also disclosed.Type: GrantFiled: September 15, 1992Date of Patent: November 22, 1994Assignee: Epitope, Inc.Inventors: Richard K. Bestwick, Vijaya K. Mokkapati, Adolph J. Ferro
-
Patent number: 5350855Abstract: O-acylated pyridinium compounds in which the 3-hydroxy moiety derivatized specifically at its aliphatic hydroxyl group by a selected acyl group is disclosed. In various embodiments, the composition may be used as a standard for HPLC or immunoassay of pyridinoline, a pyridinoline immunogen for producing anti-pyridinoline antibodies, and a solid-phase reagent for use in an immunoassay kit. Also disclosed are methods for making and using the composition.Type: GrantFiled: September 30, 1992Date of Patent: September 27, 1994Assignee: Metra Biosystems, Inc.Inventors: Yuri Daniloff, Simon P. Robins, Brian J. Evans, David A. Pratt, Robert Lungard
-
Patent number: 5346814Abstract: A method of assessing a cell's susceptibility to cell-damaging energy, such as ionizing radiation and heat, is disclosed. The method is based on measurable changes in voltage-dependent potassium channel currents in the cell in response to the energy. Also disclosed is a method for screening drugs which are effective to sensitize a cell to cell-damaging radiation.Type: GrantFiled: October 14, 1992Date of Patent: September 13, 1994Assignee: Board of Trustees of the Leland Stanford Jr. UniversityInventors: George M. Hahn, Alie H. Saad, Amato J. Giaccia
-
Patent number: 5339829Abstract: A device for obtaining oral fluid containing substances for testing. In one embodiment, the device includes a syringe having a plunger at the end of which an absorbent pad is attached. A test assembly containing the device is also disclosed.Type: GrantFiled: August 25, 1992Date of Patent: August 23, 1994Assignee: Epitope, Inc.Inventors: Thomas R. Thieme, Andrew S. Goldstein, Stephen C. Piacentini, Nanette M. Klimkow
-
Patent number: 5338867Abstract: A method of preparing a 4'-0-demethy-4.beta.-NHR podophyllotoxin, where R is an aryl or dialkyl amino alkyl group, is disclosed. The method includes reacting H.sub.2 NR under basic conditions with a mixture of .alpha. and .beta. epimers of 4'-0-demethyl-4-bromo-podophyllotoxin, to form an epimeric mixture of the 4'-0-demethyl-4-NHR-podophyllotoxin compounds, removing acidic impurities which bind to silica gel in a dichloromethane solvent, and crystallizing 4'-0-demethyl-4.beta.-NHR-podophyllotoxin from its .alpha. epimer.Type: GrantFiled: April 24, 1992Date of Patent: August 16, 1994Assignee: Genelabs Technologies, Inc.Inventors: William Choy, Jen Chen, Bijan Almassian